Speaker illustration

Doctor Rasha Kaddoura

Hamad Medical Corporation Heart Hospital, Doha (Qatar)

Member of:

European Society of Cardiology

Rasha Kaddoura, MSc (Pharm), Pharm D, is a clinical pharmacy specialist at the Heart Hospital, serving in the in-patient and out-patient settings. In addition to COVID-19 facilities during the pandemic. Rasha received her Post-Graduate Doctor of Pharmacy degree from the University of Toronto and her Masters Degree in Clinical Pharmacy from Szeged University – Hungary. Currently, a Master’s study candidate to pursue a degree in clinical research. Licensed and practised in Hungary, Canada and Qatar. In addition to being a pharmacy board-certified in Lebanon. Her expertise also includes drug information, drug utilization review, and medication therapy management. Served in three hospital committees, involved in preparing, updating and reviewing clinical practice guidelines, and variety of pharmacy and non-pharmacy projects. She has several published papers and served as preceptor for pharmacy undergraduate, Masters’ and Pharm D students, as well as preceptor for PGY-pharmacy residents.

Temporal trends in characteristics and outcomes in patients undergoing percutaneous mitral valve repair for secondary mitral regurgitation

Event: ESC Congress 2023

Topic: Mitral Valve Intervention

Session: Mitral valve transcatheter edge-to-edge repair


Transcatheter mitral-valve repair for functional mitral regurgitation data from the real-life in comparison with landmark randomized trials

Event: ESC Congress 2022

Topic: Mitral Valve Intervention

Session: Mitral valve interventions / TEER


Intracoronary pharmacological therapy versus aspiration thrombectomy in patients presenting with ST-segment elevation myocardial infarction (IPAT-STEMI): a systematic review and meta-analysis

Event: ESC Congress 2021 - The Digital Experience

Topic: Percutaneous Coronary Intervention (PCI)

Session: Coronary revascularisation focusing on outcomes


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb